Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease

Donavan T. Cheng, Deog Kyeom Kim, Debra A. Cockayne, Anton Belousov, Hans Bitter, Michael H. Cho, Annelyse Duvoix, Lisa D. Edwards, David A. Lomas, Bruce E. Miller, Niki Reynaert, Ruth Tal-Singer, Emiel F.M. Wouters, Alvar Agustí, Leonardo M. Fabbri, Alex Rames, Sudha Visvanathan, Stephen I. Rennard, Paul Jones, Harsukh ParmarWilliam MacNee, Gerhard Wolff, Edwin K. Silverman, Ruth J. Mayer, Sreekumar G. Pillai

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Fingerprint Dive into the research topics of 'Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

Medicine & Life Sciences